My previous response: It will be interesting to
Post# of 36537
(Total Views: 306)
Posted On: 03/07/2021 7:34:47 AM
Re: Paul Jackson #27257
My previous response:
It will be interesting to see what molecule and research center they are working with. It will take a month or two to design a study and get the FDA approval to start. Unless the MAB is already manufactured that will take months potentially. Then a trial will take time, probably 60 days depending on what they study and what the endpoints are and then another month to lock/unlind the data. Then a couple weeks or so to review and publicly announce findings.
This will take many months ONCE they finalize a deal. In the meantime at least 3 MABs are finishing up their trials and expecting results over the next few weeks.
Read More: https://investorshangout.com/post/view?id=607...z6oQbvGq5i
Update: Without going into great detail CYDY released some data on their MAB Phase 3 study on Friday. Sent out more info last night. Clearly the drug works, saving lives and reducing hospital stays by 6 days, but the primary endpoint wasn't met probably becaue they didn't have enough total patients and the patients were not distributed equally enough in the two arms of the study. The consequence... they have to enroll another 140 patients. So here we go, having to wait 2-3 more months.
Trial design is tricky with well know diseases, more so with new ones. I hope Generex is paying attention to what has happened to these other companies.
I am happy for Joe to provide more info on this important potential program. I would love to have vaccines and therapy be part of our business model.
Edit: Dr Pourhassan was on Dr Been's webcast last night. Lot's of viewers asking question via twitter and through the chat window. We need Joe, Rich and EvH to do the same for our vaccine. Following up with Dr YO wouldn't hurt.
It will be interesting to see what molecule and research center they are working with. It will take a month or two to design a study and get the FDA approval to start. Unless the MAB is already manufactured that will take months potentially. Then a trial will take time, probably 60 days depending on what they study and what the endpoints are and then another month to lock/unlind the data. Then a couple weeks or so to review and publicly announce findings.
This will take many months ONCE they finalize a deal. In the meantime at least 3 MABs are finishing up their trials and expecting results over the next few weeks.
Read More: https://investorshangout.com/post/view?id=607...z6oQbvGq5i
Update: Without going into great detail CYDY released some data on their MAB Phase 3 study on Friday. Sent out more info last night. Clearly the drug works, saving lives and reducing hospital stays by 6 days, but the primary endpoint wasn't met probably becaue they didn't have enough total patients and the patients were not distributed equally enough in the two arms of the study. The consequence... they have to enroll another 140 patients. So here we go, having to wait 2-3 more months.
Trial design is tricky with well know diseases, more so with new ones. I hope Generex is paying attention to what has happened to these other companies.
I am happy for Joe to provide more info on this important potential program. I would love to have vaccines and therapy be part of our business model.
Edit: Dr Pourhassan was on Dr Been's webcast last night. Lot's of viewers asking question via twitter and through the chat window. We need Joe, Rich and EvH to do the same for our vaccine. Following up with Dr YO wouldn't hurt.
(6)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼